$QNRX Quoin Pharmaceuticals ripping +24% AH 🚀 🔹 Big after-hours surge as biotech momentum hits this rare disease play 📈 🔹 FDA conditionally accepted QYLEKI™

$QNRX Quoin Pharmaceuticals ripping +24% AH 🚀 🔹 Big after-hours surge as biotech momentum hits this rare disease play 📈 🔹 FDA conditionally accepted QYLEKI™ as the proposed brand name for QRX003, its lead Netherton Syndrome treatment 💊 🔹 QRX003 holds Orphan Drug Designation in the U.S., EU, an…